Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Q32 Bio Inc (QTTB)  
$43.69 5.29 (10.8%) as of 4:30 Mon 9/23


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 47,934,000
Market Cap: 2.09(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $9.56 - $49.79
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Homology Medicines is a genetic medicines company. Co.'s proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors to deliver single administration genetic medicines in vivo either through its gene therapy, Co.'s nuclease-free gene editing modality, or Co.'s gene therapy to express antibodies platform. Co.'s clinical programs include: HMI-102, an investigational gene therapy candidate in clinical development for the treatment of adult patients with phenylketonuria; as well as HMI-103, an investigational gene editing candidate in clinical development for the treatment of patients with PKU.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 608 22,633 60,507
Total Sell Value $0 $14,716 $27,256 $80,181
Total People Sold 0 3 3 7
Total Sell Transactions 0 3 6 15
End Date 2024-06-23 2024-03-22 2023-09-22 2022-09-22

   
Records found: 150
  Page 3 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Smith W Bradford CFO & Treasurer   •       –      –    2022-01-01 4 OE $0.00 $0 D/D 6,600 6,600     -
   Tzianabos Arthur President & CEO   •       •      –    2022-01-01 4 OE $0.00 $0 D/D 13,860 91,365     -
   Kelly Timothy P See Remarks.   •       –      –    2021-09-03 4 AS $7.70 $416 D/D (54) 0     -
   Kelly Timothy P See Remarks   •       –      –    2021-03-01 4/A AS $11.16 $69,563 D/D (6,232) 0     -
   Kelly Timothy P See Remarks.   •       –      –    2021-03-01 4 S $11.16 $69,563 D/D (6,232) 0     -
   Kelly Timothy P See Remarks.   •       –      –    2021-03-01 4 OE $2.89 $19,052 D/D 4,000 6,232     -
   Smith W Bradford CFO & Treasurer   •       –      –    2021-02-08 4 AS $14.25 $192,425 D/D (13,500) 0     -
   Smith W Bradford CFO & Treasurer   •       –      –    2021-02-08 4 OE $0.64 $8,640 D/D 13,500 13,500     -
   Kelly Timothy P See Remarks   •       –      –    2021-02-02 4 AS $13.00 $6,500 D/D (500) 0     -
   Kelly Timothy P See Remarks   •       –      –    2021-02-02 4 OE $6.63 $3,316 D/D 500 500     -
   Kelly Timothy P See Remarks   •       –      –    2021-02-01 4 AS $12.37 $49,460 D/D (4,000) 0     -
   Kelly Timothy P See Remarks   •       –      –    2021-02-01 4 OE $2.89 $19,052 D/D 4,000 4,000     -
   Kelly Timothy P See Remarks   •       –      –    2021-01-12 4 AS $13.00 $6,500 D/D (500) 0     -
   Kelly Timothy P See Remarks   •       –      –    2021-01-12 4 OE $6.63 $3,316 D/D 500 500     -
   Seymour Albert Chief Scientific Officer   •       –      –    2021-01-07 4 AS $12.05 $61,469 D/D (5,103) 129,017     -
   Seymour Albert Chief Scientific Officer   •       –      –    2021-01-06 4 AS $12.06 $119,395 D/D (9,897) 134,120     -
   Seymour Albert Chief Scientific Officer   •       –      –    2021-01-05 4 AS $11.44 $114,422 D/D (10,000) 144,017     -
   Kelly Timothy P See Remarks   •       –      –    2021-01-04 4 AS $11.50 $45,983 D/D (4,000) 0     -
   Kelly Timothy P See Remarks   •       –      –    2021-01-04 4 OE $2.89 $19,052 D/D 4,000 4,000     -
   Parmar Kush Director   –       •      –    2020-12-22 4 S $12.82 $6,410,000 I/I (500,000) 181,435     -
   Schwab Andrew J. 10% Owner   –       –       •   2020-12-22 4 S $12.82 $6,410,000 I/I (500,000) 181,435     -
   Parmar Kush Director   –       •      –    2020-12-14 4 S $11.88 $6,125,915 I/I (500,000) 201,435     -
   Schwab Andrew J. 10% Owner   –       –       •   2020-12-14 4 S $11.88 $6,125,915 I/I (500,000) 201,435     -
   Kelly Timothy P See Remarks   •       –      –    2020-03-17 4 AS $13.01 $17,109 D/D (1,315) 0     -
   Tzianabos Arthur President & CEO   •       •      –    2020-02-03 4 AS $16.16 $202,021 D/D (12,500) 77,505     -
  150 Records found
  1  2  3  4  5  6   
  Page 3 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us